tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
3M ago
Is CRBU a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRBU a Buy, Before Earnings?
3M ago
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
Premium
The Fly
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
3M ago
Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
PremiumThe FlyCaribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
3M ago
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
Premium
Company Announcements
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
3M ago
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
Premium
Company Announcements
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
3M ago
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
PremiumRatingsCaribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
6M ago
Caribou Biosciences Reports Increased Losses Amid R&D Efforts
Premium
Company Announcements
Caribou Biosciences Reports Increased Losses Amid R&D Efforts
6M ago
Caribou Biosciences reports Q2 EPS (35c), one estimate (42c)
Premium
The Fly
Caribou Biosciences reports Q2 EPS (35c), one estimate (42c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100